US Stock MarketDetailed Quotes

ARQT Arcutis Biotherapeutics

Watchlist
  • 8.670
  • +0.360+4.33%
Close Nov 1 16:00 ET
  • 8.670
  • 0.0000.00%
Post 20:01 ET
1.01BMarket Cap-5100P/E (TTM)

Arcutis Biotherapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Arcutis Biotherapeutics Q3 2024 Estimates Date

Currency：USDNov 6, 2024

Estimate YoY
Revenue
37.34M
-2.02%
EPS
-0.42
+42.47%
Analyst Rating
Strong Buy

Nov 3, 2024

Arcutis Biotherapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 46.689M--
Nov 6, 20242024/Q3-- / 37.340M--
Aug 14, 20242024/Q230.858M / 29.080M--
May 14, 20242024/Q149.569M / 15.140M--
Feb 27, 20242023/Q413.526M / 11.388M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 46.689M--
Nov 6, 20242024/Q3-- / 37.340M--
Aug 14, 20242024/Q230.858M / 29.080M--
May 14, 20242024/Q149.569M / 15.140M--
Feb 27, 20242023/Q413.526M / 11.388M--

Unlock Free Earnings Estimates

Arcutis Biotherapeutics Earnings Reports

  • Arcutis Biotherapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 14 16:18 ET

  • Arcutis Biotherapeutics | 10-Q/A: Quarterly report (Amendment)

    Jul 24 16:15 ET

  • Arcutis Biotherapeutics | 10-Q: Q1 2024 Earnings Report

    May 14 22:21 ET

  • Arcutis Biotherapeutics | 10-K: FY2023 Annual Report

    Feb 27 07:50 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 3, 2024

    Strong Buy

    • Buy

      83.33%

    • Hold

      16.67%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data